Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications

The development of new drugs is often hindered by low solubility in water, a problem common to nearly 90% of natural and/or synthetic molecules in the discovery pipeline. Nanocrystalline drug technology involves the reduction in the bulk particle size down to the nanosize range, thus modifying its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingale, Elide, Bonaccorso, Angela, Carbone, Claudia, Musumeci, Teresa, Pignatello, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024479/
https://www.ncbi.nlm.nih.gov/pubmed/35456525
http://dx.doi.org/10.3390/pharmaceutics14040691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024479/
https://www.ncbi.nlm.nih.gov/pubmed/35456525
http://dx.doi.org/10.3390/pharmaceutics14040691

Ejemplares similares